We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring

By LabMedica International staff writers
Posted on 25 Jun 2024
Print article
Image: The proposed self-powered, millifluidic lab-on-a-chip device to determine blood conductivity (Photo courtesy of Advanced Materials/DOI: 10.1002/adma.202403568)
Image: The proposed self-powered, millifluidic lab-on-a-chip device to determine blood conductivity (Photo courtesy of Advanced Materials/DOI: 10.1002/adma.202403568)

Metabolic disorders such as diabetes and osteoporosis are rapidly increasing globally, especially in developing countries. Diagnosing these conditions generally requires blood tests; however, in remote areas with insufficient healthcare infrastructure, many individuals remain undiagnosed and untreated. Traditional diagnostic methods are invasive and labor-intensive, making real-time monitoring impractical, particularly in rural settings. Blood electrical conductivity, which reflects the concentration of key electrolytes like sodium and chloride ions, is crucial for diagnosing various health issues. These electrolytes play a vital role in many physiological processes, but measuring blood conductivity faces challenges such as electrode polarization, limited access to samples, and maintaining consistent blood temperature. Moreover, measuring conductivity at frequencies below 100 Hz, essential for a deeper understanding of blood's electrical properties and underlying biological functions, presents additional difficulties. Researchers are now advancing a novel device that generates electricity from blood to measure its conductivity, thereby facilitating medical care anywhere.

A research team at the University of Pittsburgh (Pittsburgh, PA, USA) has developed a portable millifluidic nanogenerator lab-on-a-chip device that can measure blood conductivity at low frequencies. This device uses blood as a conductive agent within a triboelectric nanogenerator (TENG). The TENG system harnesses mechanical energy from the blood and converts it into electricity through triboelectrification, where electron transfer occurs between contacting materials during movements such as compression or sliding.

This electron transfer and subsequent charge separation create a voltage difference that propels an electric current. The device measures the voltage generated under specific loading conditions to ascertain the blood's electrical conductivity. Its self-powering capability allows for the miniaturization of this innovative blood-based nanogenerator. The team employed AI models to predict blood conductivity directly from the voltage patterns produced by the device, and comparative tests with traditional methods have validated its accuracy. This breakthrough paves the way for deploying diagnostics directly to people's homes. Additionally, blood-powered nanogenerators could operate internally, utilizing the body's own blood chemistry for self-powered diagnostics.

“As the fields of nanotechnology and microfluidics continue to advance, there is a growing opportunity to develop lab-on-a-chip devices capable of surrounding the constraints of modern medical care,” said Amir Alavi, assistant professor of civil and environmental engineering at Pitt’s Swanson School of Engineering. “These technologies could potentially transform healthcare by offering quick and convenient diagnostics, ultimately improving patient outcomes and the effectiveness of medical services.”

Related Links:
University of Pittsburgh

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
Myeloperoxidase Assay
IDK MPO ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.